Bourse Direct SA (EPA:BSD)
4.280
-0.020 (-0.47%)
Aug 5, 2025, 5:35 PM CET
Regulus Therapeutics Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Trading Asset Securities | - | 11.36 | 14.38 | 10.71 | 20.32 | 14.33 | Upgrade |
Accounts Receivable | - | 20.69 | 25.44 | 24.18 | 35.16 | 13.16 | Upgrade |
Other Receivables | - | 976.45 | 1,002 | 952.44 | 772.58 | 1,020 | Upgrade |
Property, Plant & Equipment | - | 6.88 | 5.99 | 7 | 7.28 | 3.21 | Upgrade |
Goodwill | - | 21.05 | 21.05 | 21.05 | 21.05 | 13.57 | Upgrade |
Other Intangible Assets | - | 7.52 | 6.89 | 6.51 | 5.67 | 5.24 | Upgrade |
Investments in Debt & Equity Securities | - | 54.38 | 69.24 | 67.16 | 107.74 | 115.04 | Upgrade |
Other Current Assets | - | 71.47 | 162.2 | 238.19 | 383.15 | - | Upgrade |
Long-Term Deferred Tax Assets | - | 0.9 | 0.97 | 0.5 | 0.58 | 0.44 | Upgrade |
Other Long-Term Assets | - | 0.54 | 0.51 | 0.52 | 0.63 | 0.56 | Upgrade |
Total Assets | - | 1,171 | 1,309 | 1,328 | 1,354 | 1,185 | Upgrade |
Accounts Payable | - | 1,005 | 1,123 | 1,159 | 1,128 | 948.3 | Upgrade |
Accrued Expenses | - | 11.48 | 8.88 | 6.29 | 7.5 | 33.97 | Upgrade |
Current Portion of Long-Term Debt | - | 39.06 | 56.45 | 53.36 | 92.78 | 101.21 | Upgrade |
Other Current Liabilities | - | 23.11 | 26.13 | 28.98 | 42.88 | 26.89 | Upgrade |
Long-Term Leases | - | 3.56 | 4.12 | 4.44 | 5.17 | 1.29 | Upgrade |
Long-Term Unearned Revenue | - | 0.05 | 0.09 | 0.04 | - | - | Upgrade |
Other Long-Term Liabilities | - | 5.16 | 7.11 | 6.04 | 8.51 | 7.81 | Upgrade |
Total Liabilities | - | 1,091 | 1,233 | 1,260 | 1,287 | 1,122 | Upgrade |
Common Stock | - | 13.23 | 13.23 | 13.5 | 13.88 | 14.06 | Upgrade |
Additional Paid-In Capital | - | 19.33 | 19.33 | 19.33 | 22.12 | 23 | Upgrade |
Retained Earnings | - | 46.65 | 42.04 | 34.11 | 29.91 | - | Upgrade |
Comprehensive Income & Other | - | 6.94 | 1.21 | 1.98 | 4.06 | 29.7 | Upgrade |
Total Common Equity | - | 80.06 | 75.04 | 67.6 | 66.25 | 63.55 | Upgrade |
Minority Interest | - | 0.45 | 0.82 | 0.78 | 0.72 | - | Upgrade |
Shareholders' Equity | - | 80.51 | 75.86 | 68.38 | 66.97 | 63.55 | Upgrade |
Total Liabilities & Equity | - | 1,171 | 1,309 | 1,328 | 1,354 | 1,185 | Upgrade |
Total Debt | - | 42.62 | 60.57 | 57.8 | 97.95 | 102.5 | Upgrade |
Net Cash (Debt) | - | -31.26 | -46.19 | -47.09 | -77.63 | -88.17 | Upgrade |
Net Cash Per Share | - | -0.59 | -0.87 | -0.88 | -1.39 | -1.57 | Upgrade |
Filing Date Shares Outstanding | - | 51.61 | 52.77 | 53.56 | 53.81 | 54.08 | Upgrade |
Total Common Shares Outstanding | - | 51.61 | 52.77 | 53.56 | 53.81 | 54.08 | Upgrade |
Working Capital | - | 0.11 | -14.97 | -21.85 | -60 | -65.41 | Upgrade |
Book Value Per Share | - | 1.55 | 1.42 | 1.26 | 1.23 | 1.18 | Upgrade |
Tangible Book Value | - | 51.49 | 47.1 | 40.04 | 39.52 | 44.74 | Upgrade |
Tangible Book Value Per Share | - | 1.00 | 0.89 | 0.75 | 0.73 | 0.83 | Upgrade |
Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.